![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 50, 49003-49010, December 13, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cellular and Structural Biology, University of Colorado Health Sciences Center, Denver, Colorado 80262
Received for publication, June 10, 2002, and in revised form, October 3, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Several Rabs, including Rab11, regulate the
traffic and sorting of proteins in the endosomal pathway. Recently, six
novel Rab11 family interacting proteins (FIPs) were identified.
Although they share little overall sequence homology, all FIPs contain a conserved Rab11-binding domain. Here we investigate the role of FIPs as Rab11-targeting proteins and show that the Rab11-binding domain assumes an Members of the Rab GTPase family have emerged as important
regulators of vesicular trafficking, with specific Rab proteins governing specific membrane trafficking steps (1). Rab1 and Rab2 seem
to regulate protein transport from the endoplasmic reticulum to the
Golgi (2, 3), whereas Rab6 was shown to be important for
intra-Golgi transport (4). At least six Rab proteins (Rabs 4, 5, 7, 9, 11, and 15) regulate trafficking and sorting of endocytosed material
between endosomes, lysosomes, and the plasma membrane (5-7). Rab11, in
particular, plays an essential role in protein recycling from endosomes
to the plasma membrane (6). Furthermore, Rab11 has been implicated in
regulating several other membrane transport pathways, including
phagocytosis (8), apical targeting in epithelial cells (9),
insulin-dependent glucose transporter 4 (GLUT4)
transport to plasma membrane (10), and protein transport from endosomes
to the trans-Golgi network (11).
Despite considerable effort, the mechanism of Rab11 action remains to
be fully understood. Cycling between GTP- and GDP-bound forms of Rab
proteins is suggested to regulate the recruitment of various effectors
to cellular membranes, thereby affecting the targeting and fusion of
transport vesicles (12). Thus, the ability of Rabs to interact with
several different effector molecules, which are localized in different
trafficking pathways, could be the basis for the specific functions of
Rab proteins in a variety of cellular processes. Consistent with the
role of Rab11 in multiple membrane traffic pathways, several
Rab11-interacting proteins have been identified. Using yeast two-hybrid
experiments, it has been shown that Rab11 interacts with the myosin Vb
globular tail domain, suggesting that Rab11 may regulate the membrane
traffic by docking the myosin motor to transferrin receptor-containing transport vesicles (13). Another Rab11-binding protein,
Rab11BP/Rabphilin-11, has also been shown to regulate transferrin
receptor delivery to recycling endosomes
(RE)1 (14, 15). In addition,
we and others have recently identified six novel Rab11-interacting
proteins belonging to a family of proteins known as the family of
Rab11-interacting proteins (FIPs) (16-20). Although they share little
overall sequence homology, all FIP proteins contain a conserved
Rab11-binding domain (RBD) at the C terminus of the protein (19).
Although RBD is necessary for Rab11 binding (19), the essential
elements of the Rab11-binding domain remain to be defined. Furthermore,
the role of FIP proteins in membrane traffic is unclear. Given that
most mammalian cells express several FIP proteins, one possible role of
FIP proteins could be the formation of mutually exclusive complexes
with Rab11, thereby directing the recruitment of Rab11 to different
membrane traffic pathways. Indeed, the finding that all FIPs seem to
contain equivalent, highly conserved Rab11-binding domains is
consistent with that idea. In this study, we characterized the impact
of Rab11/FIP binding on endocytic traffic. We showed that the RBD assumes an Cell Lines, Plasmids, and Antibodies--
HeLa cells were
cultured in Dulbecco's modified Eagle's medium supplemented with 10%
(v/v) heat-inactivated fetal bovine serum and 2 mM
L-glutamine. HeLa cells were transiently transfected using
an electroporation procedure as described previously (19). Polyclonal
rabbit anti-Rip11 antibody was described previously (18). Polyclonal
rabbit anti-FIP2, anti-Eferin, and anti-Rab11 antibodies were prepared
by immunization with recombinant FIP2 (490-624), Eferin (600-759),
and full-length Rab11a, respectively. All recombinant proteins were
expressed as GST fusion proteins as described previously (21). Rabbit
polyclonal anti-GFP antibody was obtained from
Clontech Inc. Mouse monoclonal anti-myc (9E10) antibody was purchased from Santa Cruz Biotechnology. Texas Red and
fluorescin-conjugated secondary antibodies were obtained from Jackson
Immunoresearch Laboratories. Texas Red-labeled transferrin was obtained
from Molecular Probes. cDNAs encoding Rip11, FIP2, and Eferin were
fused to the C terminus of pEGFP-N3 vector
(Clontech). cDNA encoding Rip11 (490-652) was
fused to the N terminus of pEGFP-C1 (Clontech) or
pCMV-Tag3a (Stratagene) vectors.
Expression and Purification of Proteins--
GST gene fusion
constructs were made by cloning Rab11a, FIP2, Eferin, and Rip11a
fragments into pGEX-KG (Amersham Biosciences) and transforming them
into BL-21 codon + Escherichia coli (Stratagene). GST
proteins were expressed and purified using glutathione beads as
described previously (21). GST-fusion proteins were eluted from
glutathione column by thrombin cleavage. Soluble proteins were then
repurified using a size-exclusion S200 column (Pharmacia). The
fractions containing the protein of interest were pooled and checked
for purity by separating on SDS-PAGE, followed by Coomassie Blue
staining. The molecular weight of purified proteins was determined by
mass spectroscopy (University of Colorado Health Sciences Center core
facilities). The molar extinction coefficient
(E280) for each protein was calculated using UV
spectrophotometry by absorption at 205- and 280-nm wavelengths as
described previously (32). Protein concentrations were determined
either by Bradford assay (33) (in vitro binding
experiments) or using E280 and absorption at 280 nm (CD experiments).
In Vitro Binding Assays and CD Spectroscopy--
In
vitro binding assays were performed using 25 µl of packed
glutathione beads coated with 20 µg of GST-fusion protein in a final
volume of 500 µl and varying amounts of soluble proteins. Reaction
buffer consisted of 50 mM HEPES, pH 7.4, 150 mM
NaCl, 5 mM MgCl2, 0.5 mM
CaCl2, 0.1% Triton X-100, 0.1% bovine serum albumin, 1 mM phenylmethylsulfonyl fluoride, and 1.5 µM
pepstatin. Guanosine 5'-3-O-(thio)triphosphate or guanosine
5'-O-(2-thio)diphosphate were added where indicated.
Reactions were kept suspended at room temperature for 30 min, pelleted
at 2000 × g for 3 min, and washed three times in 1 ml
of reaction buffer without bovine serum albumin but with 100 nM guanosine 5'-3-O-(thio)triphosphate or
guanosine 5'-O-(2-thio)diphosphate, as necessary. Bound
proteins were eluted with 1% SDS. Proteins were separated on SDS-PAGE
and stained with Coomassie Blue or immunoblotted. Gels were imaged
using a Bio-Rad gel documentation system and quantified using Quantity
One software (version 4.1.1; Bio-Rad).
CD spectra and thermal melts were recorded on a Jasco J-810
spectrophotometer equipped with a thermoelectric temperature
controller. Measurements were made using a 0.1-cm path-length quartz
cuvette. Thermal unfolding experiments were performed by measuring the CD signal at 222 nm (1 min averaging time) in 2 °C steps. Data were
converted to a fraction of folded protein by fitting the lower and
upper base lines as 0 and 100% folded, respectively.
Separation of Cellular Membranes Using Preformed Iodixanol
Gradient--
HeLa cells were grown to 70% confluence on four 100-mm
plates. Cells were then scraped off in phosphate-buffered saline,
washed, and resuspended in homogenization medium (0.25 M
sucrose, 78 mM KCl, 8.37 mM CaCl2,
10 mM EGTA, 50 mM HEPES, pH 7.2, and 4 mM MgCl2). Cells were ruptured using 20 strokes
of a Dounce homogenizer. Pellet debris and nuclei were sedimented at
1,000 × g. A 5-20% iodixanol gradient was formed
using a two-chamber gradient maker, and 1,000 × g
supernatants were loaded on top of the gradient. Gradient was
centrifuged at 90,000 × g for 18 h. Gradient was then collected in 24 0.5-ml fractions and analyzed by immunoblotting.
Confocal and Deconvolution Microscopy, Image Processing, and
Quantification--
For immunofluorescence microscopy, cells were
fixed with 4% paraformaldehyde for 15 min. Cells were then
permeabilized with 0.4% saponin, and nonspecific sites were blocked
with phosphate-buffered saline containing 0.2% bovine serum albumin,
0.4% saponin, and 1% fetal bovine serum. After incubation with
antibodies, samples were extensively washed and mounted in VectaShield
(Vector Laboratories). Cells were imaged with inverted Zeiss Axiovert
200 M deconvolution microscope. Image processing was done using
Intelligent Imaging Innovations three-dimensional rendering and
exploration software. For quantitation of colocalization of transiently
transfected HeLa cells, only cells expressing low amounts of protein
were used. The cells were considered low expressers when the
fluorescence of GFP-tagged protein was similar (no more then 2-fold
higher) to the fluorescence obtained from the antibodies against the
endogenous protein with which it was being costained. All images were
digitally deconvolved before the analysis. The background fluorescence
was calculated by imaging an empty field. The background fluorescence was then subtracted from all the images before quantitation.
Transferrin (Tf)-TxR Recycling Assays--
For analysis of
transferrin recycling, HeLa cells were plated on collagen-coated glass
coverslips and grown to 60% confluence. Cells were washed with
phosphate-buffered saline and incubated for 1 h at 4 °C in
serum-free, HEPES-buffered, Dulbecco's modified Eagle's medium with
20 µg/ml of Texas Red-conjugated transferrin (Molecular Probes).
Cells were then washed extensively, returned to 37 °C, and incubated
in serum-supplemented Dulbecco's modified Eagle's medium containing
0.2 mg/ml of unlabeled transferrin. At each time point, cells were
fixed with 4% paraformaldehyde and imaged using an inverted Zeiss
Axiovert 200 M deconvolution microscope.
Biochemical Characterization of Rab11 and FIP Protein
Interactions--
Since the identification of Rip11 (18), the family
of Rab11-interacting proteins has grown to include six members: Rip11, FIP2, RCP, Eferin, FIP4, and FIP1 (Fig.
1A) (16, 18-20). Based on
sequence homology, all FIPs can be divided into three classes (Fig.
1A). Class I FIPs (Rip11 and FIP2) contain a C2 domain at the N-terminal end of the protein. Class II FIPs (Eferin and FIP4) contain two EF-hand domains. Class III includes only one member, FIP1,
which exhibits no homology to known protein domains. The common feature
of all FIP proteins is the presence of a highly conserved, 20-amino
acid motif at the C terminus of the protein, known as Rab11/25 binding
domain (RBD) (19). Although this domain has been shown to be necessary
and sufficient for binding to Rab11 and Rab25, it is unlikely that the
RBD represents the entire Rab11- and FIP-interacting interface. Indeed,
Rab11 binding to an RBD peptide is not GTP-dependent (19).
Furthermore, Rab11 binding affinity to the RBD peptide is measured in
the millimolar range (data not shown), suggesting that other motifs may
be important for mediating Rab11 binding. Interestingly, in addition to
the RBD domain, all FIPs also contain a predicted
Despite the apparent requirement of an
The data presented above suggest that the RBD in its FIP Proteins Form Mutually Exclusive Complexes with
Rab11--
Because Rip11 interacts with Rab11 via RBD domain with 1:1
stoichiometry, we investigated the possibility that various FIPs form
mutually exclusive complexes with Rab11. To test this, we measured
Rab11 binding to GST-Rip11 (490-652) and GST-Eferin (665-759) in the
presence of increasing concentrations of soluble Rip11 (490-652). As
shown in Fig. 3K, soluble
Rip11 (490-652) inhibited Rab11 binding to Rip11 and to Eferin in a
concentration-dependent manner, suggesting that FIP
proteins compete for Rab11 binding.
That, however, does not discount the possibility that individual
Rab11/FIP complexes may oligomerize, thus forming large protein complexes that include several different FIPs. Indeed, Rip11, as well
as some other FIP proteins, have been shown to form dimers in a
Rab11-independent manner
(16).2 To address that
possibility, we immunoprecipitated Rip11 from HeLa cells and
immunoblotted precipitants for the presence of Eferin protein. As shown
in Fig. 3L, neither Eferin nor FIP2 coprecipitated with
Rip11 protein complex (left). Rip11 and Eferin did coprecipitate with
Rab11, suggesting that both FIPs do bind Rab11 in vivo.
These data indicate that FIP2, Eferin, and Rip11 form mutually
exclusive complexes with Rab11.
Considering the fact that FIPs compete with each other for binding to
Rab11, they would be expected to "share" cellular Rab11. Indeed,
myc-Rab11a only partially colocalized with any individual FIP, such as
Rip11 (36.5 ± 1.39%) and Eferin (22.73 ± 0.32%), in
transiently transfected HeLa cells (Figs. 3, A-D, and
4G). That colocalization was
dependent on Rab11 activity, because a dominant-negative Rab11a mutant
(S25N) showed very little colocalization with either Rip11 (4.34 ± 2.98%) or Eferin (6.77 ± 1.98%) (Figs. 3J and
4G). To determine whether various FIPs are localized to the
same cellular membranes, we transfected HeLa cells with Rip11-GFP and
immunostained them with anti-Eferin antibodies. As shown in Fig. 3,
E and F, Rip11 and Eferin localized to different
organelles with very little overlap between them (8.1 ± 4.3%).
Thus, Rip11 and Eferin seemed to play roles in distinct
Rab11-dependent membrane traffic pathways. Consistent with
that, brefeldin A treatment resulted in tubulation of Rip11-containing
organelles, but had little effect on Eferin-containing membranes (Fig.
3, G and H). Interestingly, not all FIPs were
segregated onto distinct endocytic compartments. Although Rip11 and
FIP2 also formed mutually exclusive complexes with Rab11 (data not
shown), they did exhibit some overlap (54 ± 6.2%) (Fig.
3I).
Immunofluorescence analysis of FIP proteins suggests that they may be
localized to overlapping but distinct subpopulations of endosomes. To
test that, membranes from HeLa cells were separated using preformed
linear 5-20% iodixanol gradient (Fig. 4A) and immunoblotted for the presence of Rip11, FIP2, and Eferin (Fig. 4B). Consistent with immunofluorescence microscopy data, all
FIP proteins were present in the fractions containing endosomal
membranes and displayed overlapping but distinct distribution patterns.
FIP Proteins Regulate Rab11 Targeting to Endocytic
Membranes--
Given the fact that FIPs compete with each other for
binding to Rab11, it would be expected that overexpression of any FIP should increase its colocalization with Rab11 GTPase. Indeed, transient
expression of Eferin-GFP (Fig. 4, C and D) or
Rip11-GFP (Fig. 4, E and F) significantly
increased their colocalization with Rab11 (Fig. 4G).
Furthermore, a similar effect was also obtained by overexpressing
GFP-Rip11 (490-653) (Fig. 4G).
Interestingly, overexpression of Rip11 (490-653) caused extensive
tubulation of Rab11-positive endocytic membranes (Fig.
5, A and B).
Consistent with the mutually exclusive complex formation of FIPs with
Rab11, those tubules were devoid of Eferin (Fig. 5C) and
FIP2 (Fig. 5D). Thus, overexpression of Rip11 and Eferin, and especially Rip11 (490-653), seemed to sequester most of the Rab11
away from other FIP proteins. To our surprise, overexpression of
GFP-Rip11 (490-653) did not change the localization of endogenous Eferin and FIP2. Despite that, Eferin and FIP2 showed very little colocalization with Rab11 (Fig. 5G); they were still
localized to punctuate membranous structures (Fig. 5, C and
D). Thus, membrane association of FIP2 and Eferin seemed to
be independent of Rab11 binding, suggesting that Rab11 was not involved
in recruiting FIP proteins to their corresponding endocytic
compartment.
To test whether Rab11 was required for FIP binding to membranes, we
transfected HeLa cells with GFP-Rip11 (490-653)-I629E construct.
Because the I629E mutation eliminates Rip11 binding to Rab11 (Fig.
2B), the localization of Rip11 (490-653)-I629E would be
independent of Rab11 association. As shown in the Fig. 5F,
GFP-Rip11 (490-653)-I629E did localize to Rab11-positive structures in
the cell periphery but had no effect on Rab11 distribution (Fig.
5E). Furthermore, whereas I629E mutation inhibited
coprecipitation of GFP-Rip11 (490-653) with Rab11, GFP-Rip11
(490-653)-I629E mutants were still capable of binding to cellular
membranes (Fig. 5H). We must note, however, that the I629E
mutation increased the amount of GFP-Rip11 (490-653) present in the
cytosol (data not shown; Fig. 5, F and H). Thus,
whereas Rip11 (490-653) can be targeted to membranes independently of
Rab11, Rab11 might be required to stabilize Rip11 association with membranes.
Our data suggested that FIP proteins might play a role in targeting
Rab11 to different endocytic compartments by competing with each other
for binding to Rab11. Thus, overexpression of Rip11 (490-653) would be
expected to inhibit Rab11-dependent membrane traffic by
sequestering Rab11. To test this, we took advantage of a well
characterized transferrin (Tf) recycling assay (22). Endocytosed Tf is
sequentially transported through Rab5, Rab4, and Rab11 compartments
before being delivered to the plasma membrane (23, 24). The Tf
transport throughout different recycling compartments can be followed
by using Texas Red-conjugated Tf (Tf-TxR). First, Tf-TxR was bound to
plasma membrane Tf receptors by incubating HeLa cells with Tf-TxR at
4 °C for 1 h. Tf-TxR internalization was then initiated by
shifting cells to 37 °C. After 5 min, the majority of Tf-TxR was
localized to large peripheral endosomes (Fig.
6A). These compartments also
stained for EEA1 (data not shown), thus confirming their identity as
early endosomes (EE). After 20 min of incubation at 37 °C, some of
the Tf-TxR moved to perinuclear compartment (Fig. 6B). This
compartment stained for Rab11, and therefore represented RE. Finally,
after 60 min of incubation at 37 °C most of the Tf-TxR moved to RE,
with trace staining left on EE (Fig. 6C).
To test whether Rip11 (490-653) had any effect on Tf traffic, we
transfected HeLa cells with GFP-Rip11 (490-653) (Fig. 6E, green, and G, green) and then followed
Tf-TxR transport through EE and RE. After 5 min of internalization,
Tf-TxR could be detected in peripheral EE, proving that Rip11
(490-653) had no effect on Tf-TxR endocytosis and delivery to EE (Fig.
6, D and E). Overexpression of GFP-Rip11
(490-653), however, did inhibit Tf-TxR delivery to RE. Even after 60 min of incubation at 37 °C, Tf-TxR remained largely confined to EE
(Fig. 6F). Rip11 (490-653)-induced tubules remained largely
devoid of any transferrin receptor-TxR (Fig. 6G). Rip11
(490-653) effect was dependent on Rab11 binding because GFP-Rip11
(490-653)-I629E did not inhibit Tf-TxR transport to RE (Fig. 6,
H-J). Thus, overexpression of Rip11 (490-653)
seemed to inhibit transport from EE to RE, presumably by sequestering Rab11 and making it unavailable for other Rab11 effectors.
The key step in understanding endocytic transport is
characterization of interactions between Rab GTPase and its binding
partners. The identification of multiple Rab11 binding proteins
presents a challenge in determining how Rab11 regulates protein
transport between plasma membrane and endocytic compartments. One
possibility is that several Rab11-interacting proteins form a large
protein complex that is involved in coordinating the sequential
transport of cargo through various endocytic domains. Our data,
however, suggest the existence of several distinct Rab11-containing
complexes. The finding that FIP family proteins form mutually exclusive
complexes with Rab11 suggests that FIPs play an essential role in
regulating the assembly and cellular localization of Rab11-targeting patches.
Rab11 has been implicated in the regulation of multiple membrane
traffic pathways, including phagocytosis (8),
insulin-dependent GLUT4 trafficking (10), apical transport
in epithelial cells (9), and EE-to-trans-Golgi network transport (11).
Thus, it is tempting to speculate that different Rab11/FIP complexes may regulate distinct membrane transport steps/pathways. Consistent with this, various FIPs have different tissue expression patterns. For
instance, Rip11 is enriched in kidney epithelial cells (18), whereas
FIP4 seems to be expressed almost exclusively in brain tissue (25). In
addition, we demonstrated here that Rip11, Eferin, and FIP2 had an
overlapping but distinctly different cellular distribution patterns.
Finally, previous studies implicated the involvement of FIP1, Rip11,
and FIP2 in different membrane transport pathways (18, 20, 26).
The classical Rab effector proteins are recruited to appropriate plasma
membranes through binding to Rab GTPases (1). Surprisingly, our data
revealed that FIP proteins did not require Rab11 for membrane binding.
Indeed, overexpression of a dominant-negative Rab11 mutant (Fig.
3J) or Rip11 (490-653) (Fig. 5, C and
D) had no effect on membrane binding of endogenous FIP2,
Rip11, and Eferin. Furthermore, the Rab11 binding mutant, Rip11
(490-653)-I629E, was still localized to Rab11-containing endosomes
(Fig. 5F), although with somewhat lower efficiency. These
observations raise an interesting possibility that FIPs may play a role
in targeting Rab11 to the appropriate endocytic compartments.
Consistent with that, overexpression of Rip11-GFP, FIP2-GFP, or
GFP-Rip11 (490-652) dramatically changed Rab11 distribution by
sequestering Rab11 GTPase in a subpopulation of endocytic membranes
(Fig. 5, A-D, and G).
What is the function of FIP proteins? One possibility is that they play
a role as Rab11 scaffolding proteins. Indeed, although Rabs bind to
membranes via geranylgeranyl groups attached to a C terminus of the
protein, how Rabs are targeted to specific cellular compartments
remains unclear. With their differential distribution and
Rab11-independent membrane binding, FIPs would be good candidates to
play a role of Rab11 scaffolding proteins. Another possibility is that
Rab11/FIP protein complexes are the essential components of targeting
patches involved in recruitment of additional cellular factors. Other
Rab GTPases, namely Rab5 and Rab27, were also reported to form similar
targeting patches by binding to EEA1 and melanophilin, respectively
(22, 27-29). Recent reports show that both Rab11 and FIP2 are involved
in recruiting myosin Vb to transport vesicles (13, 20). Furthermore,
Eferin was shown to interact with ADP-ribosylation factors (ARF5 and
ARF6) (30, 31). Thus, it is tempting to speculate that class II FIPs
(Eferin and FIP4) may regulate transport vesicle budding via
interactions with ARF GTPases, whereas class I FIPs (Rip11 and FIP2)
may be involved in regulating the motility of transport vesicles. The
requirement of Rab11/FIP complex formation for the recruitment of
additional membrane transport regulators could be the mechanism of
imparting spatial and temporal constraints to the trafficking and
fusion of transport vesicles/tubules. Interestingly, our CD data
suggested that Rab11 binding to Rip11 results in conformational changes
in one or both binding partners (Fig. 2, D-G). This could result in exposure of a cryptic binding site that could be used to bind
the other membrane traffic regulators, such as molecular motors.
In conclusion, FIP proteins may play a role as Rab11 scaffolding
proteins, in this way ensuring the targeting of Rab11 to appropriate
endocytic compartments. Upon Rab11 binding, Rab11/FIP complexes then
may serve as targeting patches for the recruitment of additional
cellular factors, such as molecular motors or ARF GTPases. In
principle, this mechanism would allow cells to modify and regulate
various endocytic membrane transport pathways by changing the
expression levels and localization of FIP proteins.
-helical structure, with the conserved residues forming a hydrophobic Rab11-binding patch. This hydrophobic patch mediates the formation of mutually exclusive complexes between Rab11
and various members of FIP protein family. Furthermore, the formation
of Rab11/FIP complexes regulates Rab11 localization by recruiting it to
distinct endocytic compartments. Thus, we propose that Rab11/FIP
complexes serve as targeting patches, regulating Rab11 localization and
recruitment of additional cellular factors to different endocytic compartments.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical structure, with the conserved residues forming a
hydrophobic, Rab11-binding patch. In addition, we demonstrated that
FIPs compete with each other for binding to Rab11 in vitro and form mutually exclusive complexes with Rab11 in vivo.
Finally, we showed that FIP proteins regulate Rab11 localization by
recruiting it to distinct membranous organelles. Thus, we propose that
Rab11/FIP complexes serve as targeting patches regulating Rab11
localization and recruitment of additional cellular factors to
different endocytic compartments.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helix at the C terminus of the protein (Fig. 1A). To test whether these
helices might be important for Rab11 binding, we created Rip11
(490-652), FIP2 (378-511), and Eferin (665-759) truncation mutants
that contained only RBD domain and predicted
-helix. CD analysis of
Rip11 (490-652) (Fig. 2, D,
F, and G) and FIP2 (378-511) (data not shown)
confirmed that the C termini of both these proteins are highly
structured (melting temperature, 68 °C) and predominantly
-helical. To test whether the
-helix is required for Rip11
binding to Rab11, we incubated GST-Rip11 (490-652)-coated glutathione
beads with increasing concentrations of soluble recombinant Rab11a. As
shown in the Fig. 1, B and C, addition of an
-helical motif to RBD increased the relative binding of Rip11
binding to Rab11 (EC50, 5 µM) but not Rab4.
Furthermore, Rip11 (490-652) binding to Rab11 was
GTP-dependent (Fig. 1B, inset),
compared with Rip11 (630-652), which contains only the RBD domain
(19). Similar binding affinities (Fig. 1B) and
GTP-dependence (data not shown) were also observed for FIP2 (378-511)
and Eferin (665-759).

View larger version (33K):
[in a new window]
Fig. 1.
Biochemical characterization of Rab11 binding
domain. A, schematic representation of FIP proteins.
B and C, to determine the affinities of Rip11
(490-652), FIP2 (378-511), and Eferin (665-759) binding to Rab11a,
the glutathione bead pull-down assay was done using various
concentrations of recombinant Rab11a in the presence of either
guanosine 5'-3-O-(thio)triphosphate (GTP
S) or
guanosine 5'-O-(2-thio)diphosphate (GDB
S)
(B, inset). In B, plotted data are the
means of at least three independent experiments.

View larger version (45K):
[in a new window]
Fig. 2.
Hydrophobic patch formed by RBD domain is
required for Rip11 and Rab11 interactions. A, helical wheel
representation of Rip11-RBD domain (620-639). An asterisk
marks the isoleucine mutated in B. B, recombinant
Rab11a was incubated with glutathione beads coated with either GST or
various GST-Rip11 (490-652) mutants. Bound Rab11 was visualized by
immunoblotting with anti-Rab11 antibodies. C-G, Rab11-Rip11
(490-652) complex was formed using glutathione beads coated with
GST-Rip11 (490-652). Complex was then eluted by thrombin cleavage and
analyzed by either by Coomassie Blue staining (C) or CD
spectroscopy (D-G). D, CD spectra of Rip11
(490-652), Rab11a, and Rip11 (490-652)-Rab11 complex were gathered at
37 °C. Rab11+Rip11 represents added Rip11 (490-652) and
Rab11a individual spectra. All proteins used for CD analysis were
repurified using gel-filtration chromatography (inset).
G, the protein folding was monitored at 222-nm wavelengths.
The data were converted to a fraction of folded protein by fitting the
lower and upper base lines as 0 and 100% folded,
respectively.
-helical domain for Rab11
binding, there is little sequence homology among FIP proteins outside
of the RBD domain. Thus, how the specificity for Rab11 is encoded
within the FIP family of proteins remains unclear. One possibility is
that RBD must be in the helical conformation to mediate Rab11-FIP
interactions efficiently. Indeed, RBD does overlap with the last two
heptads of the
-helical domain. Furthermore, when plotted in the
-helical conformation, all conserved hydrophobic residues of the RBD
domain form a hydrophobic patch (Fig. 2A, black).
Substitution of the central isoleucine (Fig. 2A,
asterisk) with glutamic acid (I629E) completely abolished
Rab11 binding, whereas a conservative substitution with valine (I629V)
had no effect on Rip11 association to Rab11 (Fig. 2B).
-helical
conformation, mediates FIP protein binding to Rab11 GTPase. To
determine the stoichiometry of the FIP-Rab11 complex, we purified a
Rab11-Rip11 (490-652) complex and subjected it to SDS-PAGE and CD
analysis. As shown in the Fig. 2C, Rab11 and Rip11 form a
complex with 1:1 stoichiometry. Interestingly, CD analysis of the
Rab11-Rip11 (490-652) complex suggests that the binding of Rip11 to
Rab11 results in the induction of additional
-helices in one or both binding partners (Fig. 2D). This also results in
stabilization of the protein structure, indicated by an increase in the
Rab-Rip11 complex melting temperature (77.9 ± 1.48 °C)
compared with Rab11a (72.3 ± 0.35 °C) and Rip11 (490-652)
(68.9 ± 0.202 °C) alone (Fig. 2, E, F,
and G).

View larger version (60K):
[in a new window]
Fig. 3.
Rab11 forms mutually exclusive complexes with
FIP proteins. A-D, HeLa cells were stained
for Rab11 (A-D, red), Rip11
(B, green), and Eferin (D,
green). E-H, HeLa cells, transfected
with Rip11-GFP (E-H, green) were
either left untreated (E and F) or treated with 5 µg/ml brefeldin A (G and H) and then stained
for Eferin (F and H, red).
I, HeLa cells were transfected with FIP2-GFP
(green) and stained for Rip11 (red).
J, HeLa cells were transfected with myc-Rab11-S25N, fixed,
and stained for myc (green) and Rip11 (red).
Scale bars, 5 µm (A and B), 2 µm
(E-J). K, glutathione beads coated
with either GST-Rip11 (490-652) (top) or GST-Eferin
(665-759) (bottom) were incubated with recombinant Rab11a
in the presence of varying concentrations of Rip11 (490-652). Bound
Rab11a was visualized by immunoblotting. L, Rip11
(left) or Rab11 (right) were
immunoprecipitated from HeLa cell Triton X-100 lysates.
Precipitates were then analyzed for the presence of Rip11, Rab11,
Eferin, and FIP2 by immunoblotting.

View larger version (36K):
[in a new window]
Fig. 4.
Overexpression of Rip11-GFP and Eferin-GFP
changes Rab11 localization. A and B,
membranes from HeLa cells were separated using preformed iodixanol
gradient (A). The fractions containing plasma membrane
(PM), recycling endosomes (RE), and early
endosomes (EE) were determined using biotinylated
transferrin and EEA1 antibodies (B). Fractions were then
probed for the presence of Rip11, FIP2, Eferin, Rab11, and Rab5
(B). C-F, HeLa cells expressing Eferin-GFP
(C and D, green) or Rip11-GFP
(E and F, green) were fixed and
stained for Rab11 (D and F, red). Scale
bars, 2 µm. G, quantitation of Rab11 colocalization
with endogenous Rip11, endogenous Eferin, Rip11-GFP, Eferin-GFP, and
GFP-Rip11 (490-653) proteins. Presented data are the means ± S.E. of at least five randomly chosen cells.

View larger version (30K):
[in a new window]
Fig. 5.
Overexpression of Rip11 (490-653) decreases
Rab11 colocalization with FIP2 and Eferin. A-D, Hela
cells expressing GFP-Rip11 (490-653) (A and
B-D, green) were stained for Rab11
(B, red), Eferin (C, red),
and FIP2 (D, red). (E and
F) HeLa cells expressing GFP-Rip11 (490-653)-I629E
(F, green) were stained for Rab11 (E
and F, red). Scale bars, 2 µm
(A-C, and E); 5 µm (D); and 1 µm
(F). G, quantitation of myc-Rab11 colocalization
with endogenous Rip11 and Eferin. Left two bars are from
cells expressing only myc-Rab11a; right two bars are from
the cells coexpressing myc-Rab11a and GFP-Rip11 (490-653). Data are
presented as the means from four randomly chosen cells. H,
HeLa cells were transiently transfected with either wild-type GFP-Rip11
(490-652) (wt) or GFP-Rip11 (490-653)-I629E mutant
(I629E). Cells were then subjected to either Triton X-100
extraction followed by immunoprecipitation with anti-GFP antibodies
(top) or subcellular fractionation to cytosol
(Cyto) and membranes (Mem) (bottom).
Cytosol and membrane fractions were then analyzed for the presence of
GFP-Rip11 (490-652) (anti-GFP), GFP-Rip11
(490-652)-I629E (anti-GFP), or integral membrane
protein syntaxin 13 (anti-syntaxin 13).

View larger version (39K):
[in a new window]
Fig. 6.
Rip11 (490-653) inhibits Tf recycling via
perinuclear recycling endosomes. A-C, Tf-TxR was bound
to plasma membrane of HeLa cells by incubating at 4 °C for 60 min.
Cells were then shifted to 37 °C incubator and incubated for 5 min
(A), 20 min (B) or 60 min (C).
D-G, HeLa cells, transiently transfected with GFP-Rip11
(490-653) (E, green and G,
green), were incubated with Tf-TxR at 4 °C. Tf-TxR was
then chased at 37 °C for either 5 min (D and
E, red) or 60 min (F and G,
red). H-J, HeLa cells, transiently transfected
with GFP-Rip11 (490-653)-I629E (I, green), were
incubated with Tf-TxR and chased at 37 °C for either 5 min
(H and I, red) or 60 min
(J). Scale bars, 2 µm.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Drs. Karl H. Pfenninger and Kathryn Howell (both from the University of Colorado Health Sciences Center) for all assistance and insightful discussions. We also thank Dr. Paul Cachia and Nancy Berton for the assistance in CD experiments. We are grateful to Drs. Alexander Sorkin and Alex Franzcusoff (both from the University of Colorado Health Sciences Center) for the critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Cellular and
Structural Biology, University of Colorado Health Sciences Center B111,
4200 E. Ninth Ave., Denver, CO 80262. Tel.: 303-315-1725; Fax:
303-315-4729; E-mail: rytis.prekeris@uchsc.edu.
Published, JBC Papers in Press, October 9, 2002, DOI 10.1074/jbc.M205728200
2 J. Meyers and R. Prekeris, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: RE, recycling endosomes; FIP, Rab11 family interacting protein; RBD, Rab11-binding domain; GST, glutathione S-transferase; GFP, green fluorescent protein; Tf, transferrin; TxR, Texas Red; EE, early endosome.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Gonzalez, L., Jr., and Scheller, R. H. (1999) Cell 96, 755-758[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Tisdale, E. J.,
Bourne, J. R.,
Khosravi-Far, R.,
Der, C. J.,
and Balch, W. E.
(1992)
J. Cell Biol.
119,
749-761 |
| 3. |
Plutner, H.,
Cox, A. D.,
Pind, S.,
Khosravi-Far, R.,
Bourne, J. R.,
Schwaninger, R.,
Der, C. J.,
and Balch, W. E.
(1991)
J. Cell Biol.
115,
31-43 |
| 4. |
Martinez, O.,
Schmidt, A.,
Salamero, J.,
Hoflack, B.,
Roa, M.,
and Goud, B.
(1994)
J. Cell Biol.
127,
1575-1588 |
| 5. | van der Sluijs, P., Hull, M., Webster, P., Male, P., Goud, B., and Mellman, I. (1992) Cell 70, 729-740[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Ullrich, O.,
Reinsch, S.,
Urbe, S.,
Zerial, M.,
and Parton, R. G.
(1996)
J. Cell Biol.
135,
913-924 |
| 7. | Chavrier, P., and Goud, B. (1999) Curr. Opin. Cell Biol. 11, 466-475[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Cox, D.,
Lee, D. J.,
Dale, B. M.,
Calafat, J.,
and Greenberg, S.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
680-685 |
| 9. |
Wang, X.,
Kumar, R.,
Navarre, J.,
Casanova, J. E.,
and Goldenring, J. R.
(2000)
J. Biol. Chem.
275,
29138-29146 |
| 10. | Kessler, A., Tomas, E., Immler, D., Meyer, H. E., Zorzano, A., and Eckel, J. (2000) Diabetologia 43, 1518-1527[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Wilcke, M.,
Johannes, L.,
Galli, T.,
Mayau, V.,
Goud, B.,
and Salamero, J.
(2000)
J. Cell Biol.
151,
1207-1220 |
| 12. | Bourne, H. R., Sanders, D. A., and McCormick, F. (1991) Nature 349, 117-127[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Lapierre, L. A.,
Kumar, R.,
Hales, C. M.,
Navarre, J.,
Bhartur, S. G.,
Burnette, J. O.,
Provance, D. W., Jr.,
Mercer, J. A.,
Bahler, M.,
and Goldenring, J. R.
(2001)
Mol. Biol. Cell
12,
1843-1857 |
| 14. |
Mammoto, A.,
Ohtsuka, T.,
Hotta, I.,
Sasaki, T.,
and Takai, Y.
(1999)
J. Biol. Chem.
274,
25517-25524 |
| 15. |
Zeng, J.,
Ren, M.,
Gravotta, D., De,
Lemos-Chiarandini, C.,
Lui, M.,
Erdjument-Bromage, H.,
Tempst, P., Xu, G.,
Shen, T. H.,
Morimoto, T.,
Adesnik, M.,
and Sabatini, D. D.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2840-2845 |
| 16. | Walace, D. M., Lindsay, A. J., Hendrick, A. G., and McCaffrey, M. W. (2002) Biochem. Biophys. Res. Commun. 292, 909-915[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Lindsay, A. J.,
Hendrick, A. G.,
Cantalupo, G.,
Senic-Matuglia, F.,
Goud, B.,
Bucci, C.,
and McCafrey, M. W.
(2002)
J. Biol. Chem.
277,
12190-12199 |
| 18. | Prekeris, R., Klumperman, J., and Scheller, R. H. (2000) Mol Cell 6, 1437-1448[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Prekeris, R.,
Davies, J. M.,
and Scheller, R. H.
(2001)
J. Biol. Chem.
276,
38966-38970 |
| 20. |
Hales, C.,
Griner, R.,
Hobdy-Henderson, K.,
Dorn, M.,
Hardy, D.,
Kumar, R.,
Navarre, J.,
Chan, E.,
Lapierre, L.,
and Goldenring, J.
(2001)
J. Biol. Chem.
276,
39067-39075 |
| 21. |
Prekeris, R.,
Klumperman, J.,
Chen, Y. A.,
and Scheller, R. H.
(1998)
J. Cell Biol.
143,
957-971 |
| 22. | De Renzis, S., Sonnichsen, B., and Zerial, M. (2002) Nat. Cell Biol. 4, 124-133[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Sonnichsen, B., De,
Renzis, S.,
Nielsen, E.,
Rietdorf, J.,
and Zerial, M.
(2000)
J. Cell Biol.
149,
901-914 |
| 24. |
Daro, E.,
van der Sliujis, P.,
Galli, T.,
and Mellman, I.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9559-9564 |
| 25. | Nagase, T., Ishikawa, K., Suyama, M., Kikuno, R., Hirosawa, M., Miyajima, N., Tanaka, A., Kotani, H., Nomura, N., and Ohara, O. (1998) DNA Res. 5, 355-364[Abstract] |
| 26. |
Lindsay, A. J.,
and McCaffrey, M. W.
(2002)
J. Biol. Chem.
277,
27193-27199 |
| 27. | Zerial, M., and McBride, H. (2001) Nat. Rev. Mol. Cell. Biol. 2, 107-117[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Wu, X.,
Wang, F.,
Rao, K.,
Sellers, J. R.,
and Hammer, J. A., 3rd.
(2002)
Mol. Biol. Cell
13,
1735-1749 |
| 29. | Wu, X. S., Rao, K., Zhang, H., Wang, F., Sellers, J. R., Matesic, L. E., Copeland, N. G., Jenkins, N. A., and Hammer, J. A., 3rd. (2002) Nat. Cell Biol. 4, 271-278[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Shin, O. H.,
Ross, A. H.,
Mihai, I.,
and Exton, J. H.
(1999)
J. Biol. Chem.
274,
36609-36615 |
| 31. | Shin, O. H., Couvillon, A. D., and Exton, J. H. (2001) Biochemistry 40, 10846-10852[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Stoscheck, C. M. (1990) Methods Enzymol. 182, 50-69[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Bradford, M. M. (1976) Anal Biochem 72, 248-254[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
T. J. Utley, N. A. Ducharme, V. Varthakavi, B. E. Shepherd, P. J. Santangelo, M. E. Lindquist, J. R. Goldenring, and J. E. Crowe Jr. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2 PNAS, July 22, 2008; 105(29): 10209 - 10214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Manderson, J. G. Kay, L. A. Hammond, D. L. Brown, and J. L. Stow Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNF{alpha} J. Cell Biol., October 3, 2007; 178(1): 57 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uzan-Gafsou, H. Bausinger, F. Proamer, S. Monier, D. Lipsker, J.-P. Cazenave, B. Goud, H. de la Salle, D. Hanau, and J. Salamero Rab11A Controls the Biogenesis of Birbeck Granules by Regulating Langerin Recycling and Stability Mol. Biol. Cell, August 1, 2007; 18(8): 3169 - 3179. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. X. Li, A. K. Satoh, and D. F. Ready Myosin V, Rab11, and dRip11 direct apical secretion and cellular morphogenesis in developing Drosophila photoreceptors J. Cell Biol., May 21, 2007; 177(4): 659 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shiba, H. Koga, H.-W. Shin, M. Kawasaki, R. Kato, K. Nakayama, and S. Wakatsuki Structural basis for Rab11-dependent membrane recruitment of a family of Rab11-interacting protein 3 (FIP3)/Arfophilin-1 PNAS, October 17, 2006; 103(42): 15416 - 15421. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Wilson, A. B. Fielding, G. C. Simon, X. Yu, P. D. Andrews, R. S. Hames, A. M. Frey, A. A. Peden, G. W. Gould, and R. Prekeris The FIP3-Rab11 Protein Complex Regulates Recycling Endosome Targeting to the Cleavage Furrow during Late Cytokinesis Mol. Biol. Cell, February 1, 2005; 16(2): 849 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Coumailleau, V. Das, A. Alcover, G. Raposo, S. Vandormael-Pournin, S. Le Bras, P. Baldacci, A. Dautry-Varsat, C. Babinet, and M. Cohen-Tannoudji Over-Expression of Rififylin, a New RING Finger and FYVE-like Domain-containing Protein, Inhibits Recycling from the Endocytic Recycling Compartment Mol. Biol. Cell, October 1, 2004; 15(10): 4444 - 4456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Junutula, E. Schonteich, G. M. Wilson, A. A. Peden, R. H. Scheller, and R. Prekeris Molecular Characterization of Rab11 Interactions with Members of the Family of Rab11-interacting Proteins J. Biol. Chem., August 6, 2004; 279(32): 33430 - 33437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Peden, E. Schonteich, J. Chun, J. R. Junutula, R. H. Scheller, and R. Prekeris The RCP-Rab11 Complex Regulates Endocytic Protein Sorting Mol. Biol. Cell, August 1, 2004; 15(8): 3530 - 3541. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hoekstra, D. Tyteca, and S. C. D. van IJzendoorn The subapical compartment: a traffic center in membrane polarity development J. Cell Sci., May 1, 2004; 117(11): 2183 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Brock, J. R. Goldenring, and J. E. Crowe Jr. Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells PNAS, December 9, 2003; 100(25): 15143 - 15148. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tani, M. Shibata, K. Kawase, H. Kawashima, K. Hatsuzawa, M. Nagahama, and M. Tagaya Mapping of Functional Domains of gamma -SNAP J. Biol. Chem., April 4, 2003; 278(15): 13531 - 13538. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||